[go: up one dir, main page]

SE9801090L - Odlingsmedium för animalceller - Google Patents

Odlingsmedium för animalceller

Info

Publication number
SE9801090L
SE9801090L SE9801090A SE9801090A SE9801090L SE 9801090 L SE9801090 L SE 9801090L SE 9801090 A SE9801090 A SE 9801090A SE 9801090 A SE9801090 A SE 9801090A SE 9801090 L SE9801090 L SE 9801090L
Authority
SE
Sweden
Prior art keywords
culture medium
animal cells
nutrient medium
cells
medium
Prior art date
Application number
SE9801090A
Other languages
English (en)
Other versions
SE9801090D0 (sv
SE519827C2 (sv
Inventor
Mats Jarekrans
Hans Olovsson
Original Assignee
Bionative Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionative Ab filed Critical Bionative Ab
Priority to SE9801090A priority Critical patent/SE519827C2/sv
Publication of SE9801090D0 publication Critical patent/SE9801090D0/sv
Priority to AU36331/99A priority patent/AU3633199A/en
Priority to DK99918400.5T priority patent/DK1073715T3/da
Priority to US09/647,402 priority patent/US6309862B1/en
Priority to EP99918400.5A priority patent/EP1073715B1/en
Priority to HU0102319A priority patent/HU225802B1/hu
Publication of SE9801090L publication Critical patent/SE9801090L/sv
Publication of SE519827C2 publication Critical patent/SE519827C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9801090A 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta SE519827C2 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta
AU36331/99A AU3633199A (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use
DK99918400.5T DK1073715T3 (da) 1998-03-30 1999-03-23 Dyrecellekulturmedium, der indeholder methionin, og anvendelse deraf
US09/647,402 US6309862B1 (en) 1998-03-30 1999-03-23 Methionine containing animal cell culture medium and its use
EP99918400.5A EP1073715B1 (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use
HU0102319A HU225802B1 (en) 1998-03-30 1999-03-23 Methionin containing animal cell culture medium and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta

Publications (3)

Publication Number Publication Date
SE9801090D0 SE9801090D0 (sv) 1998-03-30
SE9801090L true SE9801090L (sv) 1999-11-30
SE519827C2 SE519827C2 (sv) 2003-04-15

Family

ID=20410773

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801090A SE519827C2 (sv) 1998-03-30 1998-03-30 Näringsmedium innehållande metionin samt användning av detta

Country Status (6)

Country Link
US (1) US6309862B1 (sv)
EP (1) EP1073715B1 (sv)
AU (1) AU3633199A (sv)
DK (1) DK1073715T3 (sv)
HU (1) HU225802B1 (sv)
SE (1) SE519827C2 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054146A2 (en) * 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
US7371719B2 (en) * 2002-02-15 2008-05-13 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2004106359A2 (en) * 2002-09-23 2004-12-09 Northwestern University Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
US7554021B2 (en) * 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US7683025B2 (en) * 2002-11-14 2010-03-23 Northwestern University Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
ATE541580T1 (de) 2003-12-05 2012-02-15 Univ Northwestern Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor
AU2006206194A1 (en) * 2005-01-21 2006-07-27 Northwestern University Methods and compositions for encapsulation of cells
US7510732B2 (en) * 2005-02-16 2009-03-31 Cambridge Scientific Pty Ltd Analgesic and anti-inflammatory composition
WO2006096614A2 (en) * 2005-03-04 2006-09-14 Northwestern University Angiogenic heparin binding peptide amphiphiles
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
EP2419116A1 (en) * 2009-04-13 2012-02-22 North Western University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
US20220204920A1 (en) * 2019-05-16 2022-06-30 Formycon Ag Method for reducing methionine oxidation in recombinant proteins
TW202128745A (zh) 2019-12-06 2021-08-01 美商再生元醫藥公司 抗ｖｅｇｆ蛋白組合物及其製備方法
MX2022013812A (es) 2020-05-08 2022-12-15 Regeneron Pharma Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
HU192254B (en) 1983-12-13 1987-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing human leucocite and human gamma interferons in consecutive steps
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
US5676942A (en) 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
US5358708A (en) 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations

Also Published As

Publication number Publication date
EP1073715B1 (en) 2013-06-26
HUP0102319A2 (hu) 2001-10-28
DK1073715T3 (da) 2013-07-15
SE9801090D0 (sv) 1998-03-30
US6309862B1 (en) 2001-10-30
EP1073715A1 (en) 2001-02-07
HU225802B1 (en) 2007-09-28
HUP0102319A3 (en) 2003-03-28
AU3633199A (en) 1999-10-18
SE519827C2 (sv) 2003-04-15

Similar Documents

Publication Publication Date Title
SE9801090L (sv) Odlingsmedium för animalceller
EE9700018A (et) Bioloogilistesse tehiselunditesse kapseldatud rakkude kasvu kontrollimine
BG46601A3 (bg) Метод за получаване на авермектинови производни
HRP20020787B1 (hr) Postupak liječenja upotrebom kompleksa ligand-imunogen
ATE330468T1 (de) Lösung zur evaluierung und konservierung
NL300062I1 (nl) Osteogene middelen.
DE3586108D1 (de) Biologisch vertraegliche implantierbare behaelter auf basis von kollagen, die die konservierung und/oder die kultivierung von zellen und/oder die kontrollierte freigabe von aktivsubstanzen ermoeglicht.
AU4492096A (en) Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
DE68914582D1 (de) Endothelin-DNA und ihre Verwendung.
EP1660682A4 (en) ANTISENSE MODULATION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE EXPRESSION
EP1329461B8 (en) Method of eliminating human serum albumin polymers
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
IN2012DN02781A (sv)
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2051786T3 (es) Antibioticos glicopeptidicos pa-45052.
FR2577048B1 (fr) Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application
EP0246223A4 (en) PRODUCTION INCREASED AND STIMULATING AGENTS FOR MICROBIAL PLANTS.
CS151887A2 (en) Method of sound, physiologically normal farming animal's mamma parenchyma's growth increase
ES2067058T3 (es) Tratamiento de carnes.
RU2000102740A (ru) Способ стимуляции роста культуры вешенки обыкновенной
Kaster et al. Selective Habitation of Bacteria on" Intermediate Soft" Keratin Surfaces of the Rat Tongue
FI902442A7 (sv) Preparat och förfarande med vilka tillväxttakten och/eller födoämnenas tillgodgörande och/eller motständskraften ökas hos djur
BG49066A1 (en) Nutrient medium for additional imaginal feeding of entomophages
AR000833A1 (es) Bolo para suministrar substancias biologicamente beneficiosas a animales rumiantes.
NZ509773A (en) Casein formulations for the delivery of bioactive constituents

Legal Events

Date Code Title Description
NUG Patent has lapsed